Review Article
Prognostic Role of the Circulating Tumor Cells Detected by Cytological Methods in Gastric Cancer: A Meta-Analysis
Figure 3
Hazard ratio (HR) for OS at baseline (a), OS in during chemotherapy (b), PFS at baseline (c), PFS in during chemotherapy (d), risk ratio (RR) for DCR at baseline (e), and DCR in during chemotherapy (f). OS: overall survival; PFS: progression-free survival; DCR: disease control rate.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |